Skip to content

Study of efficacy of the Siddha medical (herbal) preparation “Mathumeha chooranam” on diabetes mellitus

Hypoglycaemic and antioxidant activity of the Siddha medical preparation “Mathumeha chooranam” in patients with diabetes mellitus

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2015/008
Enrollment
280
Registered
2015-04-08
Start date
2015-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

Participants will be recruited from the Rural Ayurvedic Hospital,Karaveddy and the Government Siddha Ayurvedic medical Clinics functioning under Vadamarachi South West Piradesha sabba, Jaffna District

Sponsors

National Centre for Advanced Studies in Humanities & Social Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed diabetes mellitus 2. Adult patients between 40-70 years of either gender 3. Fasting blood glucose equal or greater than 140mg/dl at recruitment

Exclusion criteria

Exclusion criteria: 1. Diagnosis of other illness such as GIT, Hepatic, Renal, Endocrine disorders according to Siddha diagnostic criteria. 2. Patients on allopathic drugs 3. Presence of complication of the diabetes mellitus (chronic wounds, renal disease, eye disease and peripheral neuropathy) 4. Insulin dependent diabetes mellitus 5. Those unwilling to come for regular follow - up for the entire duration of the study and any subjects considered not eligible according to the researcher’s discretion. 6. Pregnancy 7. Breast feeding 8. Having child bearing potential (Age below 45 who are not on regular contraception)

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose 2. Lipid profile 3. Alanine amino transferase 4. Aspartate amino transferase 5. Alkaline Phosphatase 6. Total antioxidant capacity of serum by Ferric reducing ability of plasma (FRAP method) [All investigations will be done on the 1st day, to establish a baseline, and then according to the following schedule. 1. Every ten days for 1 month, then monthly for a total of 3 months 2. At the end of 3 months 3. At the end of 3 months 4. At the end of 3 months 5. Monthly for a total of 3 months 6. Monthly for a total of 3 months]

Secondary

MeasureTime frame
Patient symptoms as recorded in patient diary: Thirst, hunger and frequency of urination at day and at night 2. Random blood glucose 3. Fasting blood glucose 4. HbA 1c 5. Urine for reducing substances (Benedict’s test) 6. Urine for ketones [Day 7, 14, 21, 28, 35, 42 and 49 and then monthly interval up to 3 months]

Countries

Sri Lanka

Contacts

Public ContactDr Mrs T Kumutharanjan

Senior Lecturer Gr 1

tkumutharanjan@yaho.comTel: 0214925190

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026